Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Berek

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Oncotarget|June 11, 2016
Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivoSee-Hyoung Park, Young Min Chung, Jessica Ma, et al.
The American Journal of Surgical Pathology|September 18, 2014
Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancerAnne M Mills, Sofia Liou, James M Ford, et al.
Obstetrics and Gynecology|August 2, 2007
Vulvar melanoma: a multivariable analysis of 644 patientsValerie E Sugiyama, John K Chan, Jacob Y Shin, et al.
Gynecologic Oncology|August 2, 2003
Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignanciesMichael A Gold, Joan L Walker, Jonathan S Berek, et al.
Obstetrics and Gynecology|August 25, 2010
Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancerJonathan S Berek, Eva Chalas, Mitchell Edelson, et al.
Gynecological Surgery|August 19, 2015
The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysisElizabeth A Pritts, David J Vanness, Jonathan S Berek, et al.
Scientific Reports|July 25, 2014
Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activationTheodore Hu, Young Min Chung, Michelle Guan, et al.
Seminars in Oncology Nursing|July 28, 2022
Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer SurvivorsCatherine Benedict, Sophie Fisher, Dhanya Kumar, et al.
Gynecologic Oncology|December 5, 2009
The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decadeLana E Kandalaft, Nathan Singh, John B Liao, et al.
Gynecologic Oncology|March 6, 2024
2023 FIGO staging system for endometrial cancer: The evolution of the revolutionDavid Gaffney, Xavier Matias-Guiu, David Mutch, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Oncotarget|June 11, 2016
Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivoSee-Hyoung Park, Young Min Chung, Jessica Ma, et al.
The American Journal of Surgical Pathology|September 18, 2014
Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancerAnne M Mills, Sofia Liou, James M Ford, et al.
Obstetrics and Gynecology|August 2, 2007
Vulvar melanoma: a multivariable analysis of 644 patientsValerie E Sugiyama, John K Chan, Jacob Y Shin, et al.
Gynecologic Oncology|August 2, 2003
Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignanciesMichael A Gold, Joan L Walker, Jonathan S Berek, et al.
Obstetrics and Gynecology|August 25, 2010
Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancerJonathan S Berek, Eva Chalas, Mitchell Edelson, et al.
Gynecological Surgery|August 19, 2015
The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysisElizabeth A Pritts, David J Vanness, Jonathan S Berek, et al.
Scientific Reports|July 25, 2014
Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activationTheodore Hu, Young Min Chung, Michelle Guan, et al.
Seminars in Oncology Nursing|July 28, 2022
Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer SurvivorsCatherine Benedict, Sophie Fisher, Dhanya Kumar, et al.
Gynecologic Oncology|December 5, 2009
The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decadeLana E Kandalaft, Nathan Singh, John B Liao, et al.
Gynecologic Oncology|March 6, 2024
2023 FIGO staging system for endometrial cancer: The evolution of the revolutionDavid Gaffney, Xavier Matias-Guiu, David Mutch, et al.
Pageof 14